Article Cited by others


Adverse drug reaction profile of oseltamivir in children

Dalvi Prashant S, Singh Anil, Trivedi Hiren R, Mistry Suresh D, Vyas Bhadresh R

Year : 2011| Volume: 2| Issue : 2 | Page no: 100-103

   This article has been cited by
1 Pharmacokinetics of oseltamivir in infants under the age of 1 year
Rashmi Dixit,Slade Matthews,Gulam Khandaker,Karen Walker,Marino Festa,Robert Booy
Clinical and Translational Medicine. 2016; 5(1)
[Pubmed]  [Google Scholar] [DOI]
2 Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials
Sangsang Qiu,Ye Shen,Hongqiu Pan,Jianming Wang,Qun Zhang
Infectious Diseases. 2015; 47(11): 808
[Pubmed]  [Google Scholar] [DOI]
3 A prospective study of adverse drug reactions to antiepileptic drugs in children
M. Anderson,O. Egunsola,J. Cherrill,C. Millward,A. Fakis,I. Choonara
BMJ Open. 2015; 5(6): e008298
[Pubmed]  [Google Scholar] [DOI]
4 Oseltamivir produces hypothermic and neuromuscular effects by inhibition of nicotinic acetylcholine receptor functions: Comparison to procaine and bupropion
Akihiro Fukushima,Kaori Chazono,Yuichi Hashimoto,Yui Iwajima,Shohei Yamamoto,Yasuhiro Maeda,Masahiro Ohsawa,Hideki Ono
European Journal of Pharmacology. 2015; 762: 275
[Pubmed]  [Google Scholar] [DOI]
5 A prospective observational study of oseltamivir safety and tolerability in infants and young children =24?months
Barbara A. Rath,William A. Blumentals,Mary K. Miller,Kathryn Starzyk,Boguslaw Tetiurka,Martina Wollenhaupt
Pharmacoepidemiology and Drug Safety. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
6 Reduction in sympathetic nerve activity as a possible mechanism for the hypothermic effect of oseltamivir, an anti-influenza virus drug, in normal mice
Ono, H. and Iwajima, Y. and Nagano, Y. and Chazono, K. and Maeda, Y. and Ohsawa, M. and Yamamoto, S.
Basic and Clinical Pharmacology and Toxicology. 2013; 113(1): 25-30
[Pubmed]  [Google Scholar]
7 Reduction in Sympathetic Nerve Activity as a Possible Mechanism for the Hypothermic Effect of Oseltamivir, an Anti-influenza Virus Drug, in Normal Mice
Hideki Ono,Yui Iwajima,Yuko Nagano,Kaori Chazono,Yasuhiro Maeda,Masahiro Ohsawa,Shohei Yamamoto
Basic & Clinical Pharmacology & Toxicology. 2013; 113(1): 25
[Pubmed]  [Google Scholar] [DOI]
8 Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation
Yue Tang,Heyang Zhang,Xifeng Lu,Liqun Jiang,Xinyuan Xi,Jianping Liu,Jiabi Zhu
Drug Delivery. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]
9 Two years after pandemic influenza A/2009/H1N1: what have we learned?
Cheng VC, To KK, Tse H, Hung IF, Yuen KY.
Clin Microbiol Rev.. 2012; 25(2): 223-263
[Pubmed]  [Google Scholar] [DOI]
10 Antivirals used for influenza chemoprophylaxis
Tsiodras, S. and Nikolopoulos, G. and Bonovas, S.
Current Medicinal Chemistry. 2012; 19(35): 5947-5956
[Pubmed]  [Google Scholar]
11 Two seasonsę experience with pandemic A H1N1 influenza infection in neonates
Martic, J. and Savic, N. and Jankovic, B. and Nedeljkovic, J. and Rakonjac, Z. and Pejic, K. and Markovic-Sovtic, G.
Turkish Journal of Pediatrics. 2012; 54(6): 612-616
[Pubmed]  [Google Scholar]
12 Adverse drug reaction of oseltamivir in pediatric patients
Wiwanitkit, S. and Wiwanitkit, V.
Journal of Pharmacology and Pharmacotherapeutics. 2012; 3(1): 81
[Pubmed]  [Google Scholar]


Read this article